What is GeneSyte?

Genea GeneSyte NIPS imageDuring a woman’s pregnancy, some of the baby’s DNA crosses the placenta into the mother’s bloodstream. GeneSyte is a prenatal test that involves taking a blood sample from the mother and testing for the baby’s DNA. Scientists look for changes in chromosome numbers, checking for conditions which are caused by extra or missing chromosomes. At Genea, we can test all chromosomes but some of the most commonly aware diseases we test for are Down, Edwards and Patau syndromes.

GeneSyte can also report on the sex of a baby.

What is the difference between NIPT and NIPS?

NIPT stands for Non-Invasive Prenatal Testing, it is a general term. GeneSyte is a form of NIPT. When we originally launched GeneSyte, we referred to it as NIPS, which stands for Non-Invasive Prenatal Screening which is the more accurate description.

When is the test conducted? 

Anytime from 10 weeks gestation.

However, this test works well in combination with the 12 week ultrasound. The 12 week ultrasound looks for the healthy growth of a baby, GeneSyte is looking for the chromosome health of the baby which is just as important. It is a two-step procedure.

Where does the testing occur?

Blood samples are tested at our flagship Genea laboratory in Kent Street Sydney. We were the first laboratory to conduct NIPS testing in Australia.

How long does it take to get results?

Genea has one of the fastest reporting times with an average reporting time of three to five working days.

How much does GeneSyte cost?

$445. At Genea, we also offer free genetic counselling to all our patients. Our counsellors are highly qualified, specifically in genetics and pregnancy.

How do patients access the testing?

Any doctor may order GeneSyte. GPs, obstetricians and clinicians at ultrasound units often do. Any referral is accepted, even if a doctor doesn’t have our specific request/referral form.

What is the difference between GeneSyte and other Non-Invasive Prenatal Testing on the market?

There are other products on the market that sound very similar but quite simply, they are not. The most important thing a patient wants to know is that if she has her blood collected, she will have a result. Some competitors have a 'failure to report' result 3-5% of the time. Our success of reporting is greater than 99.8%. Which means, if we fail to report, we do so less than 0.2% of the time.

As the leader of the GeneSyte team, what is your recommendation when family and friends ask you for your advice?

At the end of the day, GeneSyte offers parents to be- peace of mind. It’s reliable, fast and it is the most accurate prenatal testing on the market.

My team has a combined 25 years' experience in prenatal early pregnancy analysis, coupled with experience in genetic counselling- what we offer is world leading.

Posted: 12/12/2017 12:42:08 PM by Karen Sivieng | with 0 comments
Comments
Blog post currently doesn't have any comments.
 Security code
RSS 2.0